Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume $7.71 +0.03 (+0.39%) Closing price 04:00 PM EasternExtended Trading$7.72 +0.00 (+0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Short Interest DataGlobal X Genomics & Biotechnology ETF (GNOM) has a short interest of 8,700 shares. This marks a 47.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 63,546 shares to cover all short positions.Current Short Interest8,700 sharesPrevious Short Interest5,900 sharesChange Vs. Previous Month+47.46%Dollar Volume Sold Short$71,253.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares6,060,000 sharesPercentage of Shares Shorted0.14%Today's Trading Volume21,181 sharesAverage Trading Volume63,546 sharesToday's Volume Vs. Average33% Short Selling Global X Genomics & Biotechnology ETF? Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNOM Short Interest Over TimeGNOM Days to Cover Over TimeGNOM Percentage of Float Shorted Over Time Global X Genomics & Biotechnology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20258,700 shares $71,253.00 +47.5%N/A0.1 $8.19 4/15/20255,900 shares $45,725.00 -75.5%0.1%0.1 $7.75 3/31/202524,100 shares $191,595.00 +47.0%0.4%0.3 $7.95 3/15/202516,400 shares $144,976.00 +30.2%0.3%0.2 $8.84 2/28/202512,600 shares $116,298.00 -40.0%0.2%0.2 $9.23 2/15/202521,000 shares $208,110.00 +65.4%0.3%0.3 $9.91 1/31/202512,700 shares $129,286.00 -13.0%N/A0.2 $10.18 1/15/202514,600 shares $141,036.00 -45.3%N/A0.2 $9.66 12/31/202426,700 shares $259,257.00 -20.1%N/A0.4 $9.71 12/15/202433,400 shares $343,018.00 +62.1%N/A0.6 $10.27 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11/30/202420,600 shares $223,304.00 +174.7%N/A0.5 $10.84 11/15/20247,500 shares $72,375.00 -44.0%N/A0.2 $9.65 10/31/202413,400 shares $139,092.00 -21.2%N/A0.3 $10.38 10/15/202417,000 shares $186,660.00 -7.1%N/A0.4 $10.98 9/30/202418,300 shares $205,875.00 +21.2%N/A0.3 $11.25 9/15/202415,100 shares $171,243.06 -41.5%N/A0.3 $11.34 8/31/202425,800 shares $293,604.00 +6.6%N/A0.5 $11.38 8/15/202424,200 shares $273,387.40 +70.4%N/A0.4 $11.30 7/31/202414,200 shares $165,146.00 -10.1%N/A0.3 $11.63 7/15/202415,800 shares $179,646.00 +47.7%N/A0.3 $11.37 6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44 6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46 5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15 5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92 4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85 4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25 3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38 3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47 2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98 2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44 1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75 1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34 12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56 12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33 11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42 11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06 10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85 10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72 9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17 9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23 8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20 7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27 7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26 6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12 6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90 5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22 5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07 4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26 4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53 3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32 3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27 2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63 2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29 1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58 1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60 12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65 12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09 11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50 11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72 10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15 10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15 9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55 9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19 8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83 8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28 7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24 7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09 6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22 6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12 5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00 5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81 4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74 4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50 3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03 3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56 2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46 2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31 1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14 1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22 12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85 12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38 11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62 11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02 10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43 10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46 9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14 9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46 8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12 8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98Trump + Musk = AI’s turning point (Ad)Trump may not code… but he knows how to pick winners. And according to insiders, his administration is preparing to fast-track a new class of AI infrastructure tech. Elon Musk has already poured $51 million into it.Chris Rowe just shared the full details in a live presentation… Watch it here before it comes down. 7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93 7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64 6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89 6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83 5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50 5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75 4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87 4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55 3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44 3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45 2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77 2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47 1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07 1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32 GNOM Short Interest - Frequently Asked Questions What is Global X Genomics & Biotechnology ETF's current short interest? Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 8,700 shares of GNOM short. Learn More on Global X Genomics & Biotechnology ETF's current short interest. Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing? Global X Genomics & Biotechnology ETF saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,700 shares, an increase of 47.5% from the previous total of 5,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: First Trust Dow Jones International Internet ETF (0.38%), Democratic Large Cap Core ETF (0.84%), Siren Nasdaq NexGen Economy ETF (0.33%), Tradr 2X Short Innovation Daily ETF (12.07%), Procure Space ETF (6.05%), Sprott Energy Transition Materials ETF (0.80%), Fidelity Disruptive Medicine ETF (0.06%), AOT Growth & Innovation ETF (0.21%), Spear Alpha ETF (1.84%), Roundhill GLP-1 & Weight Loss ETF (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Global X Genomics & Biotechnology ETF stock? Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Global X Genomics & Biotechnology ETF? A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further. How often is Global X Genomics & Biotechnology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies First Trust Dow Jones International Internet ETF Short Squeeze Democratic Large Cap Core ETF Short Squeeze Siren Nasdaq NexGen Economy ETF Short Squeeze Tradr 2X Short Innovation Daily ETF Short Squeeze Procure Space ETF Short Squeeze Sprott Energy Transition Materials ETF Short Squeeze Fidelity Disruptive Medicine ETF Short Squeeze AOT Growth & Innovation ETF Short Squeeze Spear Alpha ETF Short Squeeze Roundhill GLP-1 & Weight Loss ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNOM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
